Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C RIVIER

Showing results (221-230 of 259) with videos related to

Pageof 26
Sort By:
Molecular Endocrinology (Baltimore, Md.)|July 11, 1998
FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cellsA Philips, C Teyssier, F Galtier, et al.
Endocrinology|February 2, 1999
CRF type I receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammationA V Turnbull, G W Smith, S Lee, et al.
The New England Journal of Medicine|May 8, 1980
The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic menW F Crowley, I Z Beitins, W Vale, et al.
Endocrinology|October 1, 1991
Functional recovery of the developing rat ovary after transplantation: contribution of the extrinsic innervationH E Lara, W L Dees, J K Hiney, et al.
Journal of Medicinal Chemistry|December 4, 1998
Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the ratJ Rivier, J Gulyas, A Corrigan, et al.
Psychoneuroendocrinology|January 1, 1993
Blockade of pituitary-adrenal axis activation induced by peripheral immunoneutralization of corticotropin-releasing factor does not affect the behavioral response to social defeat stress in ratsE M Pich, S C Heinrichs, C Rivier, et al.
Journal of Medicinal Chemistry|August 1, 1991
Novel gonadotropin-releasing hormone antagonists: peptides incorporating modified N omega-cyanoguanidino moietiesP Theobald, J Porter, C Rivier, et al.
Molecular Endocrinology (Baltimore, Md.)|December 1, 1988
Rapid changes in the expression of inhibin alpha-, beta A-, and beta B-subunits in ovarian cell types during the rat estrous cycleH Meunier, S B Cajander, V J Roberts, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1992
Abrogation by a potent gonadotropin-releasing hormone antagonist of the estrogen/progesterone-stimulated surge-like release of luteinizing hormone and follicle-stimulating hormone in postmenopausal womenL A Kolp, S N Pavlou, R J Urban, et al.
Current Topics in Molecular Endocrinology|January 1, 1976
Isolation and characterization of hypothalamic peptide hormonesR Burgus, M Amoss, P Brazeau, et al.
Pageof 26

Showing results (221-230 of 259) with videos related to

Sort By:
Pageof 26
Molecular Endocrinology (Baltimore, Md.)|July 11, 1998
FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cellsA Philips, C Teyssier, F Galtier, et al.
Endocrinology|February 2, 1999
CRF type I receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammationA V Turnbull, G W Smith, S Lee, et al.
The New England Journal of Medicine|May 8, 1980
The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic menW F Crowley, I Z Beitins, W Vale, et al.
Endocrinology|October 1, 1991
Functional recovery of the developing rat ovary after transplantation: contribution of the extrinsic innervationH E Lara, W L Dees, J K Hiney, et al.
Journal of Medicinal Chemistry|December 4, 1998
Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the ratJ Rivier, J Gulyas, A Corrigan, et al.
Psychoneuroendocrinology|January 1, 1993
Blockade of pituitary-adrenal axis activation induced by peripheral immunoneutralization of corticotropin-releasing factor does not affect the behavioral response to social defeat stress in ratsE M Pich, S C Heinrichs, C Rivier, et al.
Journal of Medicinal Chemistry|August 1, 1991
Novel gonadotropin-releasing hormone antagonists: peptides incorporating modified N omega-cyanoguanidino moietiesP Theobald, J Porter, C Rivier, et al.
Molecular Endocrinology (Baltimore, Md.)|December 1, 1988
Rapid changes in the expression of inhibin alpha-, beta A-, and beta B-subunits in ovarian cell types during the rat estrous cycleH Meunier, S B Cajander, V J Roberts, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1992
Abrogation by a potent gonadotropin-releasing hormone antagonist of the estrogen/progesterone-stimulated surge-like release of luteinizing hormone and follicle-stimulating hormone in postmenopausal womenL A Kolp, S N Pavlou, R J Urban, et al.
Current Topics in Molecular Endocrinology|January 1, 1976
Isolation and characterization of hypothalamic peptide hormonesR Burgus, M Amoss, P Brazeau, et al.
Pageof 26